GLP

R&D

New lay summary guidelines walk sponsors through their obligations under EU regulation No. 536/2014, due to come into force in February next year.

Oncology

Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.